Growthlisted504A

Innovacell Inc.

イノバセル（株）

Biotech · Listed 2026-02-24

Price Overview

Offer Price

¥1,350

Range: ¥1,290–¥1,350

First Day Open

—

First Day Close

—

Current Price

¥471

Post-IPO Returns

1st Day

-22.2%

7d

-21.1%

30d

-37.8%

90d

-52.5%

180d

-65.1%

1y

-65.1%

52W High

¥1,248

52W Low

¥467

Avg Volume

121,820

Business Description

Innovacell develops regenerative medicine products using proprietary cell culture technology. Focus areas include cartilage regeneration for orthopedic applications and skin regeneration for burn treatment, with regulatory approval in Japan.

Risk Factors

Regenerative medicine regulatory complexity
Manufacturing scalability challenges
Reimbursement price negotiations

Offering Details

Lead Underwriter—

Bookbuilding—

Shares (Koubo)8,400,000

Shares (Uridashi)725,300

Overallotment—